Overview

Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects

Status:
COMPLETED
Trial end date:
2020-07-11
Target enrollment:
Participant gender:
Summary
The aim of the study was to compare the pharmacodynamic properties of different doses of regular human insulin administered in capsule form twice daily in a randomised twelve-week open-label trial.
Phase:
PHASE2
Details
Lead Sponsor:
Roger New
Treatments:
Insulin